The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy

The clinical utility of anthracycline anticancer agents, especially doxorubicin, is limited by a progressive toxic cardiomyopathy linked to mitochondrial damage and cardiomyocyte apoptosis. Here we demonstrate that the post-doxorubicin mouse heart fails to upregulate the nuclear program for mitochon...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Suliman, Hagir B., Carraway, Martha Sue, Ali, Abdelwahid S., Reynolds, Chrystal M., Welty-Wolf, Karen E., Piantadosi, Claude A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Clinical Investigation 2007
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2082137/
https://ncbi.nlm.nih.gov/pubmed/18037988
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI32967
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak